Iron-calcium mineral supplements with enhanced bioavailability
US4994283A · kind A · utility
68Cited by
26References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 20, 1988 |
| Grant date | Feb 19, 1991 |
| Priority date | — |
| Expiry date | Dec 20, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA23L33/16
- WIPO fieldFood chemistry
- WIPO sectorChemistry
Abstract
Nutritional mineral supplements comprise iron compounds and calcium compounds in combination with citrates or tartrates, ascorbates, and, optionally, fructose. The tendency of calcium to inhibit the bioavailability of iron is reduced in such compositions, so that conjoint bioavailability of these two important minerals is enhanced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.